| surface area |
phenotype |
8 |
4 |
SA, brain surface area, cortical surface area, surface area |
| survey year |
cohort |
2 |
1 |
|
| susceptibility |
phenotype |
3 |
1 |
vulnerability |
| susceptibility genes |
cohort |
4 |
3 |
presumptive susceptibility gene, single susceptibility gene |
| SuSiE |
drug |
2 |
2 |
SUSIE106 |
| suspiciousness |
phenotype |
2 |
1 |
|
| sustained attention |
phenotype |
6 |
5 |
performance on sustained attention |
| Sv2a |
gene |
2 |
2 |
synaptic vesicle glycoprotein 2A |
| sweating |
phenotype |
4 |
2 |
|
| Sweden |
cohort |
10 |
4 |
Sweden, Swedish cohort, Swedish population |
| Swedish cohort |
cohort |
2 |
— |
|
| Swedish Crime Register |
cohort |
2 |
— |
|
| Swedish Hospital Discharge Register |
cohort |
2 |
— |
Hospital Discharge Register |
| Swedish individuals |
cohort |
3 |
2 |
individuals born in Sweden |
| Swedish mutation |
variant |
2 |
— |
APP_Swedish, KM670/671NL |
| Swedish population |
cohort |
3 |
2 |
Sweden, Swedish cohort, relatively homogeneous sample from Sweden |
| Swedish Twin Registry |
cohort |
5 |
2 |
STR |
| Swedish Twin Study of Child and Adolescent Development |
cohort |
2 |
1 |
TCHAD |
| SwissProt |
drug |
2 |
1 |
|
| switch error rate |
phenotype |
2 |
2 |
switch error |
